Actively Recruiting
National Registry and Prospective Study of Lymphangioleiomyomatosis in France to Understand Disease Frequency and Progression
Led by Vincent COTTIN · Updated on 2026-09-11
200
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to create a registry and prospective cohort to study lymphangioleiomyomatosis, a rare lung disease that mainly affects women. The study seeks to understand how often the disease occurs in France, its forms of severity, and how quickly it progresses. It also aims to evaluate the use of diagnostic criteria established in 2009 and assess patient management within the French National Plan for rare diseases. No treatments or interventions are administered as this is an observational study. Data will be gathered from multiple sources to improve completeness, including demographic details and medical information about disease progression. The study is coordinated by the Department of Public Health and Epidemiology in Lyon Hospitals, with data collected by research assistants. Participants provide their medical information, which will be used to track the number of cases over four years, their locations, and progression-free survival. This information will help better understand the natural course and variability of the disease. The study started in 2012 and will continue until 2028, with primary outcomes assessed after four years.
CONDITIONS
Brief Title
National Lymphangioleiomyomatosis Registry, France
Research Team
V
Vincent Cottin, MD
R
Raphaële Guelminger, CRA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here